Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2017; 17(5):375-377
DOI: 10.5428/pcar20170516
Analysis of antibacterials stock in 156 hospitals in China
1. LIU ZhengYue(Department of Pharmacy,Changhai Hospital,Second Military Medical University,Shanghai 200433,China zhengyue_liu@163.com)
2. ZHANG DanDan(Department of Pharmacy,Changhai Hospital,Second Military Medical University,Shanghai 200433,China )
3. YANG ZhangWei(Department of Pharmacy,Changhai Hospital,Second Military Medical University,Shanghai 200433,China )
4. WANG Hui(Department of Pharmacy,Changhai Hospital,Second Military Medical University,Shanghai 200433,China wanghuiuuh@163.com)
ABSTRACT  Objective: To investigate antibacterials stock in the sample hospitals,so as to provide solid evidence for the monitoring and control of antibacterials in clinical application by medical institutions and administrative departments. Methods: With the support from the monitoring and control center of antibacterials in clinical application,the status of antibacterials stock in 156 hospitals was statistically analyzed. Results: The antibacterials stock of these hospitals included 11 categories containing 150 varieties and 470 items,totaling 2242 products. Conclusion: The antibacterials stock in the sample hospitals was wide and varied. Attention should be paid to safety risks and the structure of various antibacterials should be optimized.
Welcome to PCAR! You are the number 89 reader of this article!
Please cite this article as:
LIU ZhengYue,ZHANG DanDan,YANG ZhangWei,WANG Hui,. Analysis of antibacterials stock in 156 hospitals in China[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2017; 17(5): 375-377.
References:
1. National Health and Family Planning Commission,State Administration of Traditional Chinese Medicine,Bureau of Drugs and Equipment,Ministry of Health,General Logistics Department.Guiding principle of clinical application of antibacterials (2015 ed)[EB/OL].(2015-08-27)[2016-08-04].http://www.gov.cn/xinwen/2015-08/27/content_2920799.htm. In Chinese.
2. JIANG XiaoBing,XU YaMeng,YU Tao,et al.Detection of plasmid-mediated quinolone resistance genes in Acinetobacter baumannii isolates[J].Chin J Antibiot,2016,41(5):382-387. In Chinese with English abstract.
3. U.S. Food and Drug Administration. FDA Drug Safety Communication:FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together[EB/OL].(2016-05-12)[2016-08-04]. http://www.fda.gov/Drugs/DrugSafety/ucm500143.htm.
4. CHEN Hong,ZHANG Dan,ZHONG Jie. Study on pharmacokinetics of ceftriaxone sodium-sulbactam sodium for injection in dogs[J]. Chin Hosp Pharm J,2008,28(10):793-795.In Chinese with English abstract.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口